NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

PFE

Pfizer Inc

Jun 30 • 04:00PM ET

24.24

Dollar change +0.05
Percentage change 0.21	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: BMY MRK SNY AMGN ABBV NVS JNJ GSK LLY AZN

| Held by: VTI VOO SPY IVV VTV XLV VYM COWZ VHT DVY

Scroll to Statements

Index	S&P 500	P/E	17.57	EPS (ttm)	1.38	Insider Own	0.18%	Shs Outstand	5.68B	Perf Week	0.87%
Market Cap	137.81B	Forward P/E	7.85	EPS next Y	3.09	Insider Trans	0.17%	Shs Float	5.67B	Perf Month	3.37%
Enterprise Value	182.90B	PEG	-	EPS next Q	0.57	Inst Own	67.07%	Short Float	1.88%	Perf Quarter	-3.85%
Income	7.87B	P/S	2.21	EPS this Y	-3.52%	Inst Trans	0.53%	Short Ratio	2.26	Perf Half Y	-9.35%
Sales	62.46B	P/B	1.53	EPS next Y	2.86%	ROA	3.67%	Short Interest	106.73M	Perf YTD	-8.63%
Book/sh	15.89	P/C	7.96	EPS next 5Y	-0.25%	ROE	8.62%	52W High	31.54 -23.15%	Perf Year	-11.60%
Cash/sh	3.05	P/FCF	12.28	EPS past 3/5Y	-28.65% -13.25%	ROIC	5.32%	52W Low	20.92 15.90%	Perf 3Y	-51.61%
Dividend Est.	1.71 (7.04%)	EV/EBITDA	7.59	Sales past 3/5Y	-7.84% 9.10%	Gross Margin	66.93%	Volatility	1.21% 1.54%	Perf 5Y	-21.95%
Dividend TTM	1.70 (7.01%)	EV/Sales	2.93	EPS Y/Y TTM	2770.58%	Oper. Margin	27.53%	ATR (14)	0.41	Perf 10Y	-25.45%
Dividend Ex-Date	Jul 25, 2025	Quick Ratio	0.96	Sales Y/Y TTM	13.38%	Profit Margin	12.59%	RSI (14)	56.18	Recom	2.44
Dividend Gr. 3/5Y	2.49% 2.97%	Current Ratio	1.26	EPS Q/Q	-5.13%	SMA20	0.93%	Beta	0.54	Target Price	28.11
Payout	119.94%	Debt/Eq	0.69	Sales Q/Q	-7.82%	SMA50	3.38%	Rel Volume	0.94	Prev Close	24.19
Employees	81000	LT Debt/Eq	0.64	Earnings	Apr 29 BMO	SMA200	-6.11%	Avg Volume	47.14M	Price	24.24
IPO	Jan 17, 1944	Option/Short	Yes / Yes	EPS/Sales Surpr.	38.22% -1.47%	Trades		Volume	44,456,929	Change	0.21%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-22-25	Initiated	Cantor Fitzgerald	Neutral	$24
Dec-10-24	Resumed	BofA Securities	Neutral	$29
Nov-15-24	Initiated	Wolfe Research	Underperform	$25
Oct-25-24	Resumed	Citigroup	Neutral	$30
Oct-17-24	Initiated	Bernstein	Mkt Perform	$32
Aug-07-24	Upgrade	Daiwa Securities	Neutral → Outperform
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39
Jul-17-23	Reiterated	JP Morgan	Neutral	$45 → $41
Jul-14-23	Initiated	HSBC Securities	Buy	$50
Jun-29-23	Downgrade	Credit Suisse	Outperform → Neutral	$47 → $40
May-11-23	Downgrade	Daiwa Securities	Outperform → Neutral	$38
Mar-06-23	Initiated	Jefferies	Hold	$43
Feb-07-23	Upgrade	Daiwa Securities	Neutral → Outperform	$51
Jan-26-23	Downgrade	UBS	Buy → Neutral	$55 → $47
Jan-17-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$54 → $50
Jan-04-23	Downgrade	BofA Securities	Buy → Neutral	$60

Show Previous Ratings

Today 09:50AM	BMY Loses 16.3% YTD: Should You Buy, Sell or Hold the Stock? (Zacks)
Jun-29-25 09:28PM	XtalPi and Pfizer Expand Strategic Collaboration to Advance AI-Driven Drug Discovery and Materials Science Simulations (PR Newswire)
Jun-28-25 06:35AM	3 No-Brainer Stocks to Buy for Under $100 Right Now (Motley Fool)
Jun-27-25 10:58AM	PFE's Hympavzi Phase III Hemophilia Study With Inhibitors Meets Goal (Zacks)
05:35AM	Pfizer reports positive results from Phase III BASIS trial for haemophilia (Clinical Trials Arena)
04:22AM	Loading…
04:22AM	Sickle Cell Disease Treatment Market Analysis and Forecast, 2025-2035 \| Intensifying Competition as Key Players Advance Gene and Novel Therapies (GlobeNewswire)
Jun-26-25 12:00PM	All You Need to Know About Pfizer (PFE) Rating Upgrade to Buy (Zacks)
09:30AM	Smartlys Flagship Event ADVANCE Returns: New Voices, Big Ideas, and the Future of Marketing (Business Wire)
08:05AM	Innovation in Focus: Highlights from the Two-Day London Biotechnology Show 2025 (Pharmaceutical Technology)
06:45AM	Pfizer Announces Positive Topline Phase 3 Results for HYMPAVZI in Hemophilia A or B with Inhibitors (Business Wire)
Jun-25-25 05:30PM	Pfizer Declares Third-Quarter 2025 Dividend (Business Wire)
10:02AM	Will New Drugs Enable BMY to Offset the Impact of Generic Competition? (Zacks)
10:00AM	Pfizer Invites Public to View and Listen to Webcast of August 5 Conference Call with Analysts (Business Wire)
08:00AM	Arbor Biotechnologies Appoints Mikael Dolsten, M.D., Ph.D., to Board of Directors (GlobeNewswire)
06:15AM	Alzheimers R&D resurgence driven by $16.8bn in acquisitions in 2025YTD (Pharmaceutical Technology)
12:03AM	Loading…
12:03AM	3 Reasons PFE is Risky and 1 Stock to Buy Instead (StockStory)
Jun-24-25 05:45PM	Pfizer (PFE) Surpasses Market Returns: Some Facts Worth Knowing (Zacks)
10:25AM	Pfizer to Face Several Headwinds: Can It Successfully Navigate Them? (Zacks)
08:22AM	Will AbbVie's Growing Oncology Portfolio Aid Top-line Growth? (Zacks)
07:10AM	My 5 Favorite Dirt Cheap Stocks to Buy Right Now (Motley Fool)
05:22AM	Kinase Inhibitors in Autoimmune Diseases Research Report 2025-2035 \| Market Accelerates Amid Rising Disease Prevalence, Kinase Innovation, and Demand for Safer Treatments (GlobeNewswire)
Jun-23-25 11:09PM	Pfizer's Dividend Backed by Strong Free Cash Flow (Insider Monkey)
12:48PM	Ireland Warns Thousands of Jobs at Risk From Pharma Tariffs (Bloomberg)
05:30AM	10 Stocks That Pay $100 or More in Dividends (Motley Fool)
12:09AM	The 5 Most Interesting Analyst Questions From Pfizer's Q1 Earnings Call (StockStory)
Jun-20-25 11:27AM	Gene Therapy Was the Biggest Idea in Biotech. Now It Has Lost Support on Wall Street. (Barrons.com)
10:01AM	Pfizer vs BMY: Which Oncology Drugmaker Is a Better Choice for Now? (Zacks)
09:00AM	Is Trending Stock Pfizer Inc. (PFE) a Buy Now? (Zacks)
Jun-19-25 09:47AM	Pfizer Boasts Strong Oncology Portfolio: Can it Sustain Growth? (Zacks)
03:00AM	Gene Therapy Has Lost Support on Wall Street. There's Still Hope for Big Cures. (Barrons.com)
10:00AM	Loading…
Jun-18-25 10:00AM	Trump administration weighs crackdown on pharma ads, Bloomberg says (TipRanks)
07:00AM	2 Top Stocks to Buy With Less Than $30 (Motley Fool)
Jun-17-25 07:34PM	Analyst Report: Haleon plc (Morningstar Research)
05:16PM	Trump's big beautiful bill: What the pharma industry is watching (Yahoo Finance Video)
02:39PM	Slowing Gardasil Sales Hurt MRK's Top Line: Is Recovery in the Cards? (Zacks)
11:20AM	Cantor Fitzgerald Maintains PFE At Neutral Amid Vaccine Guidance Changes and Regulatory Challenges (Insider Monkey)
11:18AM	AMD extends gains, solar stocks plummet, pharma stocks (Yahoo Finance Video)
10:32AM	Trump reportedly threatens pharma ads, disrupting $10B market (Yahoo Finance Video)
10:12AM	RFK Jr. Plans Crackdown on Pharma Ads in Threat to $10 Billion Market (Bloomberg)
09:40AM	Should Value Investors Buy Pfizer (PFE) Stock? (Zacks)
09:02AM	5 Low Price-to-Book Value Stocks That You Can Buy in June (Zacks)
04:49AM	Why I Just Bought More of This Beaten-Down 7%-Yielding Dividend Stock (Motley Fool)
Jun-16-25 11:40AM	PFE or LLY: Which Is the Better Value Stock Right Now? (Zacks)
11:20AM	EMA Accepts GSK's Filing for Expanded Use of RSV Vaccine Arexvy (Zacks)
09:29AM	4 Value Stocks to Shield Your Portfolio Amid Geopolitical Turmoil (Zacks)
09:06AM	5 Large Drug Stocks That Are Poised to Ride on Sector Recovery (Zacks)
09:00AM	Can J&J's Innovative Medicines Unit Sustain Growth Amid Stelara LOE? (Zacks)
Jun-15-25 05:47AM	Goldman Sachs Maintains a Hold Rating on Pfizer (NYSE:PFE), Retains $27 PT (Insider Monkey)
Jun-13-25 12:45PM	Senators to propose ban on drug ads to consumers, WSJ reports (TipRanks)
11:30AM	JPMorgan biotech/pharma analysts hold analyst/industry conference call (TipRanks)
09:15AM	Novartis AG (NVS) Hit a 52 Week High, Can the Run Continue? (Zacks)
Jun-12-25 10:21AM	PFE's New & Acquired Drugs Hold Key to Revenue Growth Amid Headwinds (Zacks)
08:15AM	Novavax's COVID-Flu Combo Shot Shows Strong Immune Response (Zacks)
05:00AM	Create a Portfolio of Passive Income: 3 High-Yielding Dividend Stocks That Pay More Than 5% (Motley Fool)
Jun-11-25 11:27AM	Pfizer CEO Mentioned No Drug Price Commitments by Pfizer Inc. (PFE) (Insider Monkey)
10:57AM	Trump Wants Cheaper Drugs Like Europe Has. How It Works. (Barrons.com)
10:20AM	Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel (TipRanks)
09:40AM	Pfizer says drugmakers met with Trump admin to discuss lowering drug prices (TipRanks)
Jun-10-25 04:10PM	Vaccine Stocks Mixed After RFK Jr. Fires CDC's Entire Vaccine Committee (Investor's Business Daily)
10:50AM	Merck Secures FDA Nod for New RSV Antibody Enflonsia in Infants (Zacks)
10:23AM	Top Cancer Stocks to Supercharge Your 2025 Portfolio (Zacks)
10:19AM	BlackRock, Goldman Scale Up Tax Trades in $3 Trillion SMA Boom (Bloomberg)
10:10AM	RFK Jr. removes CDC vaccine panel members: What to know (Yahoo Finance Video)
08:18AM	Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.'s Firing of Vaccine Advisors. (Barrons.com)
Jun-09-25 07:12PM	RFK Jr. Fires All 17 Members of CDC's Vaccine Advisory Board (Barrons.com)
06:09PM	Vaccine Stocks Moderna, Pfizer Hit After A Surprise Blow From RFK Jr. (Investor's Business Daily)
12:50PM	Pfizer and other drug companies make 'no commitments' to the White House on lower drug prices (Quartz)
10:18AM	Pfizer Stock Down Almost 11% YTD: Should You Buy the Dip? (Zacks)
09:00AM	Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know (Zacks)
08:33AM	No drug price pledges by Pfizer, others in talks with US government, Pfizer CEO says (Reuters)
Jun-08-25 06:35AM	3 Stocks With Mouthwatering Dividends You Can Buy Right Now (Motley Fool)
Jun-07-25 09:00AM	Failed Muni Bond Draws FBI and Sparks Ponzi-Like Fraud Claims (Bloomberg)
06:30AM	Should You Buy Pfizer Stock Right Now? (Motley Fool)
05:59AM	Patents and economies of scale support Pfizer's wide moat (GuruFocus.com)
05:23AM	2 Beaten-Down Dividend Stocks to Buy Now and Hold at Least a Decade (Motley Fool)
Jun-06-25 04:16PM	Challenges pharma companies face in push into US manufacturing (Yahoo Finance Video)
09:40AM	Was Jim Cramer Right About Pfizer Inc. (PFE)? (Insider Monkey)
09:16AM	BMY Collaborates for Oncology Drug: Will This Boost Its Portfolio? (Zacks)
07:00AM	Arvinas Announces Submission of New Drug Application to U.S. FDA for Vepdegestrant for Patients with ESR1-Mutated ER+/HER2- Advanced or Metastatic Breast Cancer (GlobeNewswire)
05:15AM	Zacks.com featured highlights JAKKS Pacific, Green Dot, Signet Jewelers, Gibraltar Industries and Pfizer (Zacks)
04:00AM	With ADCs on the rise, drugmakers embrace a new oncology pillar (Pharma Voice)
01:30AM	Despite Trade War, U.S. Drug Companies Turn to China for Key Cancer Treatments (Barrons.com)
Jun-05-25 12:10PM	5 Bargain Stocks With Low P/S Ratios & High Growth Return Potential (Zacks)
09:10AM	Pre-Tariff Pharma Stockpiling Gives Irish Economy a Huge Shot in the Arm (The Wall Street Journal)
09:10AM	Pre-Tariff Pharma Stockpiling Gives Irish Economy a Huge Booster Shot (The Wall Street Journal)
03:34AM	Better High-Yield Dividend Stock to Buy Now: Pfizer vs. Prologis (Motley Fool)
03:06AM	Here Are All 6 Stocks I've Bought Through 5 Months of 2025 (Motley Fool)
Jun-04-25 04:57AM	Zacks.com featured highlights StoneCo, Centene, CVS Health and Pfizer (Zacks)
04:47AM	EC approves Takeda ADC plus chemo for stage IIb Hodgkins lymphoma (Pharmaceutical Technology)
Jun-03-25 12:16PM	Moderna Secures FDA Nod for Next-Gen COVID-19 Vaccine mNexspike (Zacks)
12:11PM	Bristol Myers Collaborates With BNTX for Oncology Candidate (Zacks)
10:24AM	Top 4 Value Stocks to Buy as Trade Tensions Still Cloud H2 Outlook (Zacks)
07:59AM	How Moderna Went From Pandemic Hero to Vaccine Victim (The Wall Street Journal)
03:06AM	3 Safe Ultra-High-Yield Dividend Stocks -- Sporting an Average Yield of 11.35% -- That Make for No-Brainer Buys in June (Motley Fool)
Jun-02-25 09:00PM	How Moderna Went From Pandemic Hero to Vaccine Victim (The Wall Street Journal)
01:38PM	Why BioNTech Stock Soared Today (Motley Fool)
11:39AM	Bristol Myers Joins Pharma's Hottest Horserace in $11.1B Deal With BioNTech (Barrons.com)
10:00AM	Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference (Business Wire)
09:38AM	Gilead Reports Positive Data From Trodelvy, Keytruda Combo Study (Zacks)
08:46AM	Bristol Myers makes $11 billion deal with BioNTech to join the cancer-drug race (MarketWatch)

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Dolsten Mikael	Former Officer	May 23 '25	Proposed Sale	23.09	59,781	1,380,632		May 23 10:54 AM
Dolsten Mikael	Former Officer	May 05 '25	Proposed Sale	23.87	55,000	1,312,736		May 05 04:45 PM
DAMICO JENNIFER B.	SVP & Controller	Mar 04 '25	Sale	25.93	2,500	64,825	11,850	Mar 06 01:57 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 27 '25	Option Exercise	31.31	22,416	701,845	31,063	Mar 03 05:39 PM
SUSMAN SALLY	Executive Vice President	Feb 27 '25	Option Exercise	31.31	85,182	2,667,048	250,866	Mar 03 05:38 PM
SAHNI PAYAL	Executive Vice President	Feb 27 '25	Option Exercise	31.31	19,054	596,581	44,242	Mar 03 05:38 PM
McDermott Michael	Executive Vice President	Feb 27 '25	Option Exercise	31.31	48,419	1,515,999	122,413	Mar 03 05:37 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 27 '25	Option Exercise	31.31	156,914	4,912,977	309,790	Mar 03 05:37 PM
Fonseca Lidia	Executive Vice President	Feb 27 '25	Option Exercise	31.31	72,629	2,274,014	111,534	Mar 03 05:36 PM
BOURLA ALBERT	Chairman & CEO	Feb 27 '25	Option Exercise	31.31	582,823	18,248,188	931,744	Mar 03 05:36 PM
McDermott Michael	Executive Vice President	Feb 22 '25	Option Exercise	30.17	11,125	335,641	87,636	Feb 25 07:38 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 22 '25	Option Exercise	30.17	8,741	263,716	17,602	Feb 25 07:38 PM
BOURLA ALBERT	Chairman & CEO	Feb 22 '25	Option Exercise	30.17	238,399	7,192,498	570,436	Feb 25 07:06 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 22 '25	Option Exercise	30.17	85,824	2,589,310	232,775	Feb 25 07:05 PM
SAHNI PAYAL	Executive Vice President	Feb 22 '25	Option Exercise	30.17	12,714	383,581	37,099	Feb 25 07:04 PM
SUSMAN SALLY	Executive Vice President	Feb 22 '25	Option Exercise	30.17	63,573	1,917,997	225,184	Feb 25 07:02 PM
BOSHOFF CHRISTOFFEL	President, R&D	Feb 22 '25	Option Exercise	30.17	8,741	263,716	159,085	Feb 25 06:58 PM
BLAYLOCK RONALD E	Director	Feb 13 '25	Buy	25.65	19,457	499,072	27,707	Feb 14 05:16 PM
Gottlieb Scott	Director	Oct 30 '24	Buy	28.24	1,000	28,240	10,000	Oct 31 04:06 PM
DAMICO JENNIFER B.	SVP & Controller	Aug 13 '24	Sale	28.66	5,154	147,714	8,582	Aug 14 03:47 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PFE

Pfizer Inc

Upgrade your FINVIZ experience